TOP STORIES

• BUSINESS More Pharmacies Turning to Medical System Network’s Price Negotiation Service after Distribution Guidelines Introduced
  March 1, 2019

• REGULATORY MHLW to Impose Administrative Fines Only on Misleading Ads, Eyes 4.5% Charge: PMD Law
  February 28, 2019

• ACADEMIA Investigators Calling Off Trials on First Hyperlactacidemia Drug with No Significant Improvement Shown
  February 28, 2019

• BUSINESS Nihon Generic Taking Pass on June Listing of Symbicort Copies; 2 Partners Mum
  February 27, 2019

• BUSINESS Shionogi Specialty Squad Providing Deep Info on Mulpleta/Pirespa, Aims for Higher Sales with Fewer Calls
  February 26, 2019

• BUSINESS Takeda Japan Chief Says Shire Buy Only Bolsters Home Operations with No Overlaps, Nixes Job Cuts
  February 25, 2019

• TRENDS Industry Workforce Dwindling as More and More Staffers Take Voluntary Retirement; Astellas Could Cut 700 Jobs
  February 22, 2019

• REGULATORY Kymriah in Line for Japan Approval Next Month as It Gets Key Panel Nod
  February 21, 2019

• REGULATORY Japan to Roll Out Cost-Effectiveness Assessment Scheme in April
  February 21, 2019

• REGULATORY Stemirac Fetches 15 Million Yen Price Tag, Peak Sales Put at 3.7 Billion Yen
  February 20, 2019

• COMMENTARY Restructuring, Divestment Progress in Wake of Drug Pricing Overhaul
  February 20, 2019

• ORGANIZATION EFPIA Japan Chief Says CEA Selection Criteria Mar Predictability, 5 Billion Yen Sales Threshold “Too Low”
  February 19, 2019

• BUSINESS As Japan Goes Digital on Package Inserts, Distributors Fret Proposed Paper-Based Rule on “1st Delivery”
  February 18, 2019

• BUSINESS Toa, Nipro, Nihon Generic Codeveloped Symbicort Copies, Launch Timing Unclear
  February 18, 2019

• REGULATORY Japan Approves Symbicort Generics, Asthma Drug Stalwart Could Face Competition in June
  February 15, 2019

• BUSINESS Ohara’s High-Need Pediatric Cancer Drug in Limbo 2 Years after Approval due to GMP Issue
  February 15, 2019

• BUSINESS Recordati Ratcheting Up Japan Biz, Set to Enrich Rare Disease Portfolio
  February 14, 2019

• BUSINESS Generic Player Ohara Looks to Morph into Innovative Drug Maker, with Focus on Oncology
  February 13, 2019

• TRENDS Rituxan Biosimilar Grabs 30% Volume Share in Just 1 Year; Sales Expected to Double in 2019
  February 12, 2019

• ORGANIZATION 2019 Is Year to “Get Things Right”: PhRMA Japan Chairman
  February 8, 2019

ページ

• « 先頭
• ‹ Prev
• …
• 139
• 140
• 141
• 142
• 143
• 144
• 145
• 146
• 147
• …
• Next ›
• 最終 »